B Kilic, Y Guler, FN Azman, E Bostanci… - Rheumatology, 2024 - academic.oup.com
Objectives FMF is the most common hereditary monogenic fever syndrome marked by recurrent attacks of fever and polyserositis. Colchicine is the current recommended first-line …
Objectives There is no consensus on canakinumab treatment tapering and discontinuation strategies in colchicine-resistant FMF patients. In this study, we aimed to establish a …
Abstract Introduction Familial Mediterranean Fever (FMF) is the most common monogentic autoinflammatory disease. FMF results from mutations in MEFV, which lead to a pro …
S Yildirim, H Bekis Bozkurt, M Erguven - Journal of Clinical Medicine, 2025 - mdpi.com
Background/Objectives: Studies have shown that some mutations, especially M694V, are correlated with renal RI and/or AA. There are limited data about rare mutations on severity of …
EA Aydin, E Baglan, NG Kocamaz, İ Bagrul… - Clinical …, 2024 - Springer
Introduction/objectives This study aimed to evaluate the effect of canakinumab on growth parameters in children with familial Mediterranean fever (FMF). Method We conducted a …
MC Abdulla - Indian Journal of Rheumatology, 2023 - journals.lww.com
Familial Mediterranean fever (FMF, OMIM no. 249100) is an inherited autoinflammatory disorder resulting from MEFV gene mutations. A 15‑year‑old girl from Kerala, South India …
A Ringer, AM Smichowski, R Gomez, BM Virasoro… - 2022 - ard.bmj.com
Background Ocular Cicatricial Pemphigoid (OCP) is an infrequent, systemic cicatricial immune-mediated disease, belonging to the group of membranous-mucosal pemphigoids …